In vitro comparison of the prebiotic effects of two inulin-type fructans

Anaerobe

Volumn 14, Issue 5, 2008, Pages 280-286

  Pompei, Anna ^a   Cordisco, Lisa ^a   Raimondi, Stefano ^b   Amaretti, Alberto ^b   Pagnoni, Ugo Maria ^b   Matteuzzi, Diego ^a   Rossi, Maddalena ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Faecal culture; Inulin; Oligofructose; Prebiotic

Indexed keywords

ACETIC ACID; AMMONIA; FORMIC ACID; FRUCTAN; FRUCTOSE OLIGOSACCHARIDE; INULIN; LACTIC ACID; PREBIOTIC AGENT; VOLATILE ORGANIC COMPOUND;

ARTICLE; BACTERIAL METABOLISM; BIFIDOBACTERIACEAE; COMPARATIVE STUDY; FECES CULTURE; FERMENTATION; INCUBATION TIME; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; PH; POLYMERIZATION; PRIORITY JOURNAL; SOLUBILITY;

AMMONIA; BACTERIA; BIODIVERSITY; COLONY COUNT, MICROBIAL; DIETARY SUPPLEMENTS; FATTY ACIDS, VOLATILE; FECES; FERMENTATION; FRUCTANS; HYDROGEN-ION CONCENTRATION; KINETICS; LACTIC ACID; OLIGOSACCHARIDES;

EID: 56949085243     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2008.07.002     Document Type: Article

References (56)

1. van Nuenen M.H., Venema K., van der Woude J.C., and Kuipers E.J. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci 49 (2004) 485-491
2. Salminen S., Bouley C., Boutron-Ruault M.C., Cummings J.H., Franck A., Gibson G.R., et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 80 (1998) S147-S171
3. Tannock G.V. Probiotics. A critical review (1999), Horizon Scientific Press, Norfolk, UK
4. Vaughan E.E., Schut F., Heilig H.G., Zoetendal E.G., de Vos W.M., and Akkermans A.D. A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol 1 (2000) 1-12
5. Tannock G.V. Probiotics and prebiotics. Where are we going? (2002), Caister Academic Press, Norfolk, UK
6. Schiffrin E.J., and Blum S. Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr 56 Suppl 3 (2002) S60-S64
7. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28 (2004) 405-440
8. Cross M.L. Immune-signaling by orally-delivered probiotic bacteria: effects on common mucosal immuno-responses and protection at distal mucosal sites. Int J Immunopathol Pharmacol 17 (2004) 127-134
9. Hirayama K., and Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect 2 (2000) 681-686
10. Sullivan A., and Nord C.E. The place of probiotics in human intestinal infections. Int J Antimicrob Agents 20 (2002) 313-319
11. Matteuzzi D., Crociani F., and Emaldi O. Amino acids produced by bifidobacteria and some clostridia. Ann Microbiol 129B (1978) 175-181
12. Deguchi Y., Morishita T., and Mutai M. Comparative studies on synthesis of water-soluble vitamins among human species of bifidobacteria. Agric Biol Chem 49 (1985) 13-19
13. Pompei A., Cordisco L., Amaretti A., Zanoni S., Matteuzzi D., and Rossi M. Folate production by bifidobacteria. Appl Environ Microbiol 73 (2007) 179-185
14. Gibson G.R., and Roberfroid M.B. Dietary modulation of human colonic microbiota: introducing the concept of prebiotics. J Nutr 125 (1995) 1401-1412
15. Pool-Zobel B.L. Inulin-type fructans and reduction in colon cancer risk: a review of experimental and human data. Br J Nutr 93 (2005) S73-S90
16. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind placebo-controlled trial. Gastroenterology 119 (2000) 305-309
17. Cremonini F., Di Caro S., Covino M., Armuzzi A., Gabrielli M., Santarelli L., et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group triple blind placebo-controlled study. Am J Gastroenterol 97 (2002) 2744-2749
18. Furrie E., MacFarlane S., Kennedy A., Cummings J.H., O'Neil D.A., and MacFarlane G.T. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54 (2005) 242-249
19. Van Loo J.A.E., Coussement P., De Leenheer L., Hoebregs H., and Smits G. On the presence of inulin, oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 35 (1995) 525-552
20. Van der Meulen R., Avonts L., and De Vuyst L. Short fractions of oligofructose are preferentially metabolized by Bifidobacterium animalis DN-173 010. Appl Environ Microbiol 701 (2004) 923-1930
21. Falony G., Vlachou A., Verbrugghe K., and De Vuyst L. Cross-feeding between Bifidobacterium longum BB536, acetate-converting butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72 (2006) 7835-7841
22. Gibson G.R., Beatty E.R., Wang X., and Cummings J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108 (1995) 975-982
23. Rao V.A. The prebiotic properties of oligofructose at low intake levels. Nutr Res 21 (2001) 843-848
24. Tuohy K.M., Finlay R.K., Wynne A.G., and Gibson G.R. A human volunteer study on the prebiotic effects of HP-inulin: faecal bacteria enumerated using fluorescent in situ hybridization (FISH). Anaerobe 7 (2001) 113-118
25. Kolida S., Tuohy K., and Gibson G.R. Prebiotic effects of inulin, oligofructose. Br J Nutr 87 (2002) 193-197
26. Langlands S.J., Hopkins M.J., Coleman N., and Cummings J.H. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53 (2004) 1610-1616
27. McKellar R.C., and Modler H.W. Metabolism of fructooligasaccharides by Bifidobacterium spp. Appl Microbiol Biotechnol 31 (1989) 537-541
28. Gibson G.R., and Wang X. Bifidogenic properties of different types of fructo-oligosaccharides. Food Microbiol 11 (1994) 491-498
29. Kaplan H., and Hutkins R.W. Fermentation of fructooligosaccharides by lactic acid bacteria, bifidobacteria. Appl Environ Microbiol 66 (2000) 2682-2684
30. Perrin S., Fougnies C., Grill J.P., Jacobs H., and Schneider F. Fermentation of chicory fructooligosaccharides in mixtures of different degrees of polymerization by three strains of bifidobacteria. Can J Microbiol 48 (2002) 759-763
31. Palframan R.J., Gibson G.R., and Rastall R.A. Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr Issues Intest Microbiol 4 (2003) 71-75
32. Corradini C., Bianchi F., Matteuzzi D., Amaretti A., Rossi M., and Zanoni S. HPAEC-PAD, CZE with indirect UV detection as powerful tools to evaluate prebiotic properties of fructo-oligosaccharides, inulin. J Chromatogr A1054 (2004) 165-173
33. Rossi M., Corradini C., Amaretti A., Nicolini M., Pompei A., Zanoni S., et al. Fermentation of fructooligosaccharides, inulin by bifidobacteria: a comparative study of pure, fecal cultures. Appl Environ Microbiol 71 (2005) 6150-6158
34. Amaretti A., Tamburini E., Bernardi T., Pompei A., Zanoni S., Vaccari G., Matteuzzi D., et al. Substrate preference of Bifidobacterium adolescentis MB 239: compared growth on single, mixed carbohydrates. Appl Microbiol Biotechnol 73 (2006) 654-662
35. Van der Meulen R., Makras L., Verbrugghe K., Adriany T., and De Vuyst L. In vitro kinetic analysis of oligofructose consumption by Bacteroides, Bifidobacterium spp. indicates different degradation mechanisms. Appl Environ Microbiol 721 (2006) 006-1012
36. Cummings J.H., and MacFarlane G.T. The control, consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70 (1991) 443-459
37. McNail N.I., Cummings G.H., and James W.P.T. Short-chain fatty acids absorption by the human large intestine. Gut 19 (1978) 819-822
38. Hoverstad T., and Bjorneklett A. Short-chain fatty acids, bowel functions in man. Scand J Gastroenterol 19 (1984) 1059-1065
39. Livesey G., and Elia M. Short-chain fatty acids as energy source in the colon: metabolism, clinical implications. In: Cummings J.H., Rombeau J.L., and Sakata S. (Eds). Physiological, clinical aspects of short-chain fatty acids (1995), Cambridge University Press, Cambridge, UK 427-482
40. Topping D.L., and Clifton P.M. Short-chain fatty acids, human colonic function: roles of resistant starch, nonstarch polysaccharides. Physiology 81 (2001) 1031-1064
41. Rycroft C.E., Jones M.R., Gibson G.R., and Rastall R.A. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91 (2001) 878-887
42. Forest V., Clement M., Pierre F., Meflah K., and Menanteau J. Butyrate restores motilefunction, actin cytoskeletal network integrity in apc mutated mouse colon epithelial cells. Nutr Cancer 4 5 (2003) 84-92
43. Biagi G., Cipollini I., Pompei A., Zaghini G., and Matteuzzi D. Effect of a Lactobacillus animalis strain on composition metabolism of the intestinal microflora in adult dogs. Vet Microbiol 20 1-2 (2007) 124
44. Yang M.H., and Choong Y.M. A rapid gas chromatographic method for direct determination of short-chain (C2-C12) volatile organic acids in foods. Food Chem 75 (2001) 101-108
45. Cummings J.H., and Englyst H.N. Gastrointestinal effects of food carbohydrates. Am J Clin Nutr 61 (1995) 938S-945S
46. MacFarlane G.T., Gibson G.R., Drasar B.S., and Cummings J.H. Metabolic significance of the gut microflora. In: Whitehead R. (Ed). Gastrointestinal, oesophageal pathology. 2nd ed (1995), Churchill Livingstone, Edinburgh, UK 249-274
47. Cummings J.H., MacFarlane G.T., and Englyst H.N. Prebiotic digestion, fermentation. Am J Clin Nutr 73 (2001) 415S-420S
48. Pryde S.E., Duncan S.H., Hold G.L., Stewart C.S., and Flint H.J. The microbiology of butyrate formation in the human gut. FEMS Microbiol Lett 217 (2002) 133-139
49. Walker A.W., Duncan S.H., McWilliam Leitch E.C., Child M.W., and Flint H.J. pH and peptide supply can radically alter bacterial populations, short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 71 (2005) 3692-3700
50. Belenguer A., Duncan S.H., Calder A.G., Holtrop G., Louis P., Lobley G.E., and Flint H.J. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis, butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72 (2006) 3593-3599
51. Scardovi V. The genus Bifidobacterium. In: Sneath P.H.A., Mair N.S., Sharpe M.E., and Holt J.G. (Eds). Bergey's Manual of Systematic Bacteriology. 9th ed vol. 2 (1986), Williams & Wilkins, Baltimore, MD 1418-1434
52. Biavati B., and Mattarelli P. The family Bifidobacteriaceae. In: Dworkin M. (Ed). The prokaryotes: an evolving electronic resource for the microbiological community. 3rd ed (2001), Springer, New York
53. Flint H.J., Duncan S.H., Scott K.P., and Louis P. Interactions, competition within the microbial community of the human colon: links between diet, health. Environ Microbiol 9 (2007) 1101-1111
54. Aminov R.I., Walker A.W., Duncan S.H., Harmsen H.J., Welling G.W., and Flint H.J. Molecular diversity cultivation, improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol 72 (2006) 6371-6376
55. Duncan S.H., Louis P., and Flint H.J. Lactate-utilizing bacteria isolated from human feces that produce butyrate as a major fermentation product. Appl Environ Microbiol 70 (2004) 5810-5817
56. De Preter V., Vanhoutte T., Huys G., Swings J., De Vuyst L., Rutgeerts P., et al. Effects of Lactobacillus casei Shirota Bifidobacterium breve, oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 292 (2007) G358-G368